MUVON Therapeutics AG
MUVON Therapeutics is a Swiss clinical stage biotech with the goal of extending the human health span. We are developing a novel, single-use injectable tissue engineering therapy platform utilizing non-genetically modified, autologous cells for the regeneration of skeletal muscle tissue.
Our initial therapeutic focus is the treatment of stress urinary incontinence in women currently in phase II of clinical development.
Date, time and room information
May 5, 16:00 - 16:15, room Montreal
Category
Clinical stage development company
Title of the presentation
Accelerating personalized muscle regeneration from bench to bedside
Speaker information
| Name | Position | Institution |
|---|---|---|
| Deana Mohr | CEO | MUVON Therapeutics AG |
Further information for the sponsor website
